vs
Apellis Pharmaceuticals, Inc.（APLS）与Excelerate Energy, Inc.（EE）财务数据对比。点击上方公司名可切换其他公司
Excelerate Energy, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$317.6M vs $199.9M），Excelerate Energy, Inc.同比增速更快（15.7% vs -5.9%），过去两年Excelerate Energy, Inc.的营收复合增速更高（26.0% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Excelerate Energy是全球领先的灵活液化天然气（LNG）解决方案供应商，主营浮式储存再气化装置运营、LNG配送服务及一体化LNG基础设施项目，服务覆盖欧洲、亚洲、拉美、中东等地区，助力各地能源体系向低碳转型。
APLS vs EE — 直观对比
营收规模更大
EE
是对方的1.6倍
$199.9M
营收增速更快
EE
高出21.6%
-5.9%
两年增速更快
EE
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $317.6M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 22.2% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | 15.7% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSEE
| Q4 25 | $199.9M | $317.6M | ||
| Q3 25 | $458.6M | $391.0M | ||
| Q2 25 | $178.5M | $204.6M | ||
| Q1 25 | $166.8M | $315.1M | ||
| Q4 24 | $212.5M | $274.6M | ||
| Q3 24 | $196.8M | $193.4M | ||
| Q2 24 | $199.7M | $183.3M | ||
| Q1 24 | $172.3M | $200.1M |
净利润APLSEE
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | — | ||
| Q2 25 | $-42.2M | — | ||
| Q1 25 | $-92.2M | — | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | — | ||
| Q2 24 | $-37.7M | — | ||
| Q1 24 | $-66.4M | — |
营业利润率APLSEE
| Q4 25 | -25.6% | 22.2% | ||
| Q3 25 | 48.7% | 22.3% | ||
| Q2 25 | -18.6% | 21.2% | ||
| Q1 25 | -50.0% | 20.9% | ||
| Q4 24 | -12.3% | 21.9% | ||
| Q3 24 | -24.0% | 30.9% | ||
| Q2 24 | -14.7% | 27.2% | ||
| Q1 24 | -36.0% | 22.6% |
净利率APLSEE
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | — | ||
| Q2 25 | -23.6% | — | ||
| Q1 25 | -55.3% | — | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | — | ||
| Q2 24 | -18.9% | — | ||
| Q1 24 | -38.5% | — |
每股收益（稀释后）APLSEE
| Q4 25 | $-0.40 | $0.24 | ||
| Q3 25 | $1.67 | $0.43 | ||
| Q2 25 | $-0.33 | $0.15 | ||
| Q1 25 | $-0.74 | $0.46 | ||
| Q4 24 | $-0.30 | $0.42 | ||
| Q3 24 | $-0.46 | $0.35 | ||
| Q2 24 | $-0.30 | $0.26 | ||
| Q1 24 | $-0.54 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $538.2M |
| 总债务越低越好 | — | $936.3M |
| 股东权益账面价值 | $370.1M | $2.2B |
| 总资产 | $1.1B | $4.1B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资APLSEE
| Q4 25 | $466.2M | $538.2M | ||
| Q3 25 | $479.2M | $462.6M | ||
| Q2 25 | $370.0M | $426.0M | ||
| Q1 25 | $358.4M | $619.5M | ||
| Q4 24 | $411.3M | $537.5M | ||
| Q3 24 | $396.9M | $608.4M | ||
| Q2 24 | $360.1M | $609.1M | ||
| Q1 24 | $325.9M | $578.9M |
总债务APLSEE
| Q4 25 | — | $936.3M | ||
| Q3 25 | — | $942.0M | ||
| Q2 25 | — | $946.2M | ||
| Q1 25 | — | $322.6M | ||
| Q4 24 | — | $333.6M | ||
| Q3 24 | — | $345.7M | ||
| Q2 24 | — | $356.4M | ||
| Q1 24 | $93.1M | $366.9M |
股东权益APLSEE
| Q4 25 | $370.1M | $2.2B | ||
| Q3 25 | $401.2M | $2.2B | ||
| Q2 25 | $156.3M | $2.1B | ||
| Q1 25 | $164.2M | $1.9B | ||
| Q4 24 | $228.5M | $1.9B | ||
| Q3 24 | $237.1M | $1.9B | ||
| Q2 24 | $264.3M | $1.8B | ||
| Q1 24 | $266.7M | $1.8B |
总资产APLSEE
| Q4 25 | $1.1B | $4.1B | ||
| Q3 25 | $1.1B | $4.1B | ||
| Q2 25 | $821.4M | $4.0B | ||
| Q1 25 | $807.3M | $2.9B | ||
| Q4 24 | $885.1M | $2.9B | ||
| Q3 24 | $901.9M | $2.9B | ||
| Q2 24 | $904.5M | $2.9B | ||
| Q1 24 | $831.9M | $2.9B |
负债/权益比APLSEE
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | 0.35× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $104.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSEE
| Q4 25 | $-14.2M | $104.4M | ||
| Q3 25 | $108.5M | $114.9M | ||
| Q2 25 | $4.4M | $87.1M | ||
| Q1 25 | $-53.4M | $154.8M | ||
| Q4 24 | $19.4M | $49.6M | ||
| Q3 24 | $34.1M | $39.8M | ||
| Q2 24 | $-8.3M | $90.4M | ||
| Q1 24 | $-133.0M | $64.7M |
自由现金流APLSEE
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSEE
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSEE
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率APLSEE
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
EE
| Other | $179.4M | 57% |
| Revenue From Leases | $138.1M | 43% |
